Bibliographic Details
| Title: |
The Mexican Consortium of Epidemiological Studies for the Prevention, Diagnosis, and Treatment of Chronic Kidney Disease: a review of collaborating studies. |
| Alternate Title: |
Consorcio Mexicano sobre Estudios Epidemiológicos para la Prevención, Diagnóstico y Tratamiento de la Enfermedad Renal Crónica: colaboración de estudios. |
| Authors: |
Cortés-Valencia, Adrian1, Ortiz-Rodríguez, Saraí1, Balderas-Arteaga, Nydia2, Catzin-Kuhlmann, Andrés3, Correa-Rotter, Ricardo4, González-Villalpando, Clicerio1, Jiménez-Corona, Aida5, López-Ridaura, Ruy6, Mejia, Miguel7, Salmerón, Jorge8, Tamayo, Juan7, Lajous, Martín1, Denova-Gutiérrez, Edgar2 edgar.denova@insp.mx |
| Source: |
Salud Pública de México. Jul/Aug2022, Vol. 64 Issue 4, p434-442. 9p. |
| Subjects: |
CHRONIC kidney failure, TYPE 2 diabetes diagnosis, KIDNEY diseases, DIAGNOSIS, C-reactive protein |
| Abstract (English): |
Objective. To harmonize participants' information from five epidemiological studies. Materials and methods. The Mexican Consortium of Epidemiological Studies for the Prevention, Diagnosis, and Treatment of Chronic Kidney Disease (RenMex, by its Spanish acronym) was established in 2018. RenMex is a consortium of five studies: The Mexican Teachers Cohort Study; the Mexico City Diabetes Study; the Health Workers Cohort Study; the Comitán Study; and the Salt Consumption in Mexico Study, which assessed baseline serum creatinine, albumin, and C-reactive protein, all performed with standardized techniques. Results. RenMex includes 3 133 participants, with a mean age of 44.8 years, 68.8% women, 10.8% with a previous medical diagnosis of type 2 diabetes, and 24.1% living with obesity. Conclusions. In the future, RenMex will work on more detailed analyses with each cohort allowed to opt in or out for each topic according to their individual data. [ABSTRACT FROM AUTHOR] |
| Abstract (Spanish): |
Objetivo. Armonizar la información de los participantes de cinco estudios epidemiológicos en México. Material y métodos. En 2018 se constituyó el Consorcio Mexicano de Estudios Epidemiológicos para la Prevención, Diagnóstico y Tratamiento de la Enfermedad Renal Crónica (RenMex). RenMex es un consorcio de cinco estudios --Cohorte de Maestras, Estudio de Diabetes de la Ciudad de México, Estudio de cohorte de trabajadores de la salud, Estudio Comitán y Estudio de Consumo de Sal en México-- que evaluaron la creatinina, la albúmina y la proteína C reactiva, todos realizados con técnicas estandarizadas. Resultados. RenMex incluye 3 133 participantes, con una edad media de 44.8 años, 68.8% mujeres, 10.8% con diagnóstico previo de diabetes y 24.1% viviendo con obesidad. Conclusiones. En el futuro, RenMex trabajará en análisis más detallados y cada cohorte podrá optar por entrar / salir de cada tema de acuerdo con sus datos individuales. [ABSTRACT FROM AUTHOR] |
|
Copyright of Salud Pública de México is the property of Instituto Nacional de Salud Publica and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
MedicLatina |
